Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Molina

Showing results (591-600 of 647) with videos related to

Pageof 65
Sort By:
Genes, Chromosomes & Cancer|July 29, 2010
miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastomaMaria Angelica Cortez, Milena Sabrina Nicoloso, Masayoshi Shimizu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 StudyErin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2015
First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced CancerGeoffrey I Shapiro, Katherine M Bell-McGuinn, Julian R Molina, et al.
Clinical Transplantation|July 1, 2023
Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantationJoseph B Lerman, Cynthia L Green, Maria R Molina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial dataJulian R Molina, Scott H Kaufmann, Joel M Reid, et al.
JTO Clinical and Research Reports|November 24, 2025
Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLCArthi Sridhar, Aditi Singh, Scott Hansen, et al.
NPJ Precision Oncology|August 5, 2024
Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunitiesAriane Lozac'hmeur, Tyler Danek, Qidi Yang, et al.
Nature Nanotechnology|March 16, 2010
Three-dimensional tissue culture based on magnetic cell levitationGlauco R Souza, Jennifer R Molina, Robert M Raphael, et al.
Oncotarget|March 14, 2022
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patientsEric R Molina, Letitia K Chim, Salah-Eddine Lamhamedi-Cherradi, et al.
Tissue Engineering. Part A|November 8, 2019
Multimaterial Dual Gradient Three-Dimensional Printing for Osteogenic Differentiation and Spatial SegregationBrandon T Smith, Sean M Bittner, Emma Watson, et al.
Pageof 65

Showing results (591-600 of 647) with videos related to

Sort By:
Pageof 65
Genes, Chromosomes & Cancer|July 29, 2010
miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastomaMaria Angelica Cortez, Milena Sabrina Nicoloso, Masayoshi Shimizu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 StudyErin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2015
First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced CancerGeoffrey I Shapiro, Katherine M Bell-McGuinn, Julian R Molina, et al.
Clinical Transplantation|July 1, 2023
Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantationJoseph B Lerman, Cynthia L Green, Maria R Molina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial dataJulian R Molina, Scott H Kaufmann, Joel M Reid, et al.
JTO Clinical and Research Reports|November 24, 2025
Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLCArthi Sridhar, Aditi Singh, Scott Hansen, et al.
NPJ Precision Oncology|August 5, 2024
Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunitiesAriane Lozac'hmeur, Tyler Danek, Qidi Yang, et al.
Nature Nanotechnology|March 16, 2010
Three-dimensional tissue culture based on magnetic cell levitationGlauco R Souza, Jennifer R Molina, Robert M Raphael, et al.
Oncotarget|March 14, 2022
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patientsEric R Molina, Letitia K Chim, Salah-Eddine Lamhamedi-Cherradi, et al.
Tissue Engineering. Part A|November 8, 2019
Multimaterial Dual Gradient Three-Dimensional Printing for Osteogenic Differentiation and Spatial SegregationBrandon T Smith, Sean M Bittner, Emma Watson, et al.
Pageof 65